Your browser doesn't support javascript.
loading
Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma.
D'Angelo, Sandra P; Hunger, Matthias; Brohl, Andrew S; Nghiem, Paul; Bhatia, Shailender; Hamid, Omid; Mehnert, Janice M; Terheyden, Patrick; Shih, Kent C; Brownell, Isaac; Lebbé, Céleste; Lewis, Karl D; Linette, Gerald P; Milella, Michele; Schlichting, Michael; Hennessy, Meliessa H; Bharmal, Murtuza.
Afiliación
  • D'Angelo SP; Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, 300 East 66th Street, 12th Floor, New York, NY, 10065, USA. dangelos@mskcc.org.
  • Hunger M; Mapi (An ICON plc Company), Munich, Germany.
  • Brohl AS; Moffitt Cancer Center, Tampa, FL, USA.
  • Nghiem P; Division of Dermatology, Department of Medicine, Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA.
  • Bhatia S; Division of Medical Oncology, Department of Medicine, Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA.
  • Hamid O; The Angeles Clinic and Research Institute, Los Angeles, CA, USA.
  • Mehnert JM; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Terheyden P; University of Lübeck, Lübeck, Germany.
  • Shih KC; Tennessee Oncology, Nashville, TN, USA.
  • Brownell I; Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Lebbé C; Hôpital Saint-Louis, Paris, France.
  • Lewis KD; University of Colorado Cancer Center, Anschutz, Aurora, CO, USA.
  • Linette GP; Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
  • Milella M; IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Schlichting M; Merck KGaA, Darmstadt, Germany.
  • Hennessy MH; EMD Serono, Billerica, MA, USA.
  • Bharmal M; Merck KGaA, Darmstadt, Germany.
Cancer Immunol Immunother ; 68(4): 609-618, 2019 Apr.
Article en En | MEDLINE | ID: mdl-30721341
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células de Merkel / Antineoplásicos Inmunológicos / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células de Merkel / Antineoplásicos Inmunológicos / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos